AnilAnanthaneniMD

PubMed

• Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS).
  Ananthaneni, A., Zaki Al-Yafeai, Manush Sondhi, Kavya Vadlamudi, Rahul Vyas, Daniyal Nadeem, Mohammed Alawadi, Alexander Carvajal-González, Mohamed Ghoweba, Anil Anant...> ;International Journal of Cardiology. 2024 May 1
• Adult-onset Still's disease with concurrent thrombotic microangiopathy: Observations from pooled analysis for an uncommon finding.
  Anil Ananthaneni, Gaelen Shimkus, Francesca Weis, Eunice Adu-Dapaah, Rachaita Lakra, Poornima Ramadas, Samina Hayat, Ananthaneni, A.> ;European Journal of Haematology. 2024 Apr 1
• Esophageal squamous cell carcinoma at the site of tracheo-esophageal fistula repair in a patient with cystic fibrosis.
  Anil Ananthaneni, Sam Abdehou, Sudha Pandit, Ananthaneni, A., Aditya Pradeep Vyas> ;BMJ Case Reports. 2023 Aug 29
• Unusual case of pernicious anaemia masquerading as thrombotic thrombocytopenic purpura in the setting of multiple normal vitamin B12 deficiency parameters: preventing ...
  Zoya Mohammad, Anil Ananthaneni, Poornima Ramadas, Mohammad Nour Salloum, Fontenot, A.> ;Family Practice. 2023 Jun 9
• 1 citations
  Feasibility and acceptability pilot of video-based direct observed treatment (vDOT) for supporting antitubercular treatment in South India: a cohort study.
  Rashmi Rodrigues, Suman Sarah Varghese, Mohammed Mahrous, Anil Ananthaneni Kumar, Mohammed Naseer Ahmed, George D'Souza> ;BMJ Open. 2023 May 29
• De novo monocytic-M5b AML with t(8;16) (p11.2; p13.3) KAT6A/CREBBP fusion and FLT3-TKD mutation complicated by chemotherapy-induced Takotsubo cardiomyopathy.
  Anil Ananthaneni, Taras Benzar, Nazar Hafiz, Hugo Akabane> ;BMJ Case Reports. 2023 Mar 28
• Marginal zone lymphoma-associated membranous nephropathy: a rare presentation.
  R Lakra, B Zoshchuk, A Ananthaneni, P Ramadas> ;QJM. 2023 Jul 28
• Letter to the Editor: Poor Access to Ambulatory Palliative Care and Needless Aggressive Care toward the End of Life among Patients with Lung Cancer.
  Brown T, Grewal US, Ananthaneni AK, Thotamgari SR, Beedupalli K> ;Journal of palliative medicine.
• Vancomycin- and piperacillin-induced acute interstitial nephritis in a patient with lupus: A case report showcasing rapid decline in renal function.
  Oluwadamilola Adisa, Anil Ananthaneni, Bryce Rushing, Nathan Rinehouse, Phani Morisetti> ;Clinical Nephrology. Case Studies. 2023 Jan 1
• 8 citations
  Cardiovascular complications of modern multiple myeloma therapy: A pharmacovigilance study.
  Zaki Al-Yafeai, Mohamed Ghoweba, Anil Ananthaneni, Hamzah Abduljabar, David Aziz> ;British Journal of Clinical Pharmacology. 2023 Feb 1
• 1 citations
  Vaccines and Atrial Fibrillation: A Real-World Pharmacovigilance Study Based on Vaccine Adverse Event Reporting System.
  Zaki Al-Yafeai, Mohamed Ghoweba, David Aziz, Anil Ananthaneni, Muhie Dean Sabayon, Ananthaneni, A.> ;American Journal of Therapeutics. 2022 Jul 19
• Unusual presentation of small cell carcinoma with diffuse tracheal wall thickening leading to delayed diagnosis.
  Anil Ananthaneni, Kavitha Beedupalli, Ananthaneni, A.> ;BMJ Case Reports. 2022 May 12
• Perceived usefulness of receiving a potential smoking cessation intervention via mobile phones among smokers in Indonesia.
  Mochammad Fadjar Wibowo, Anil A. Kumar, Surahyo Sumarsono, Rashmi Rodrigues> ;Wellcome Open Research. 2019 Jun 11
• 26 citations
  Mobile Health for Tuberculosis Management in South India: Is Video-Based Directly Observed Treatment an Acceptable Alternative?
  Anil A. Kumar, Ayesha De Costa, Arundathi Das, G A Srinivasa, George D'Souza, Rashmi Rodrigues> ;JMIR Mhealth and Uhealth. 2019 Apr 3
• Join now to see all

Abstracts/Posters

• Immunosuppressant Drug-Associated Non-Hodgkin Lymphoma: A Real-World Pharmacovigilance Database Analysis
  Anil Ananthaneni, David Heap, Francesca Weis, Sriram Chowdary, Riya Sam, Zaki Al-Yafeai, Poornima Ramadas, 65th ASH Annual Meeting & Exposition, San Diego, CA, 11/28/2023
• Are We Diagnosing and Managing Diabetes in Patients with Sickle Cell Disorders Accurately?
  Anil Ananthaneni, Nakoma Walker, Rahul Vyas, Francesca Weis, David Heap, Sriram Chowdary, Nishith Alva, Sara Abdelaziz, Poornima Ramadas, 65th ASH Annual Meeting & Exposition, San Diego, CA, 11/28/2023
• Real-world analysis of cardiac, gastrointestinal, and hematologic toxicities between commonly used antiemetics in everyday oncology clinical practice.
  Kavitha Beedupalli, Anil Ananthaneni, Dawood Findakly, 2023 ASCO Annual Meeting, Chicago, IL, 5/31/2023
• Bortezomib-induced cardiotoxicity: Real-world data from a single-center.
  Suma Sri Chennapragada, Anil Ananthaneni, Shivani Sharma, Sindhu Priya Devarashetty, Runhua Shi, Poornima Ramadas, 2023 ASCO Annual Meeting, Chicago, IL, 5/31/2023
• Outcomes in Pregnant HbSS and HbSβ0-Thalassemia Sickle Cell Disease Patients Receiving Scheduled Exchange Transfusions: A Retrospective Study
  Anil Ananthaneni, Taras Benzar, Vishwa Grant, Kenna Leethy, Jacqueline Walton, Samip R Master, Richard Preston Mansour, Poornima Ramadas, 64th ASH Annual Meeting & Exposition, New Orleans, LA, 11/15/2022
• Comparison of Adverse Event Profiles of Rituximab, Rituximab Hycela and Rituximab Biosimilars: A Real-World Pharmacovigilance Database Analysis
  Dinesh Keerty, Anil Ananthaneni, Poornima Ramadas, Samip R Master, 64th ASH Annual Meeting & Exposition, New Orleans, LA, 11/15/2022
• ADAMTS13 Overtesting in Hospitalized Patients with Suspected TTP: A Retrospective Study
  Anil Ananthaneni, Udhayvir Singh Grewal, Tyiesha Sharron Brown, Zaki Al-Yafeai, Samip R. Master, Kavitha Beedupalli, 64th ASH Annual Meeting & Exposition, New Orleans, LA, 11/15/2022
• AML-336 De Novo M5b AML With t(8;16) (p11.2; p13.3) KAT6A/CREBBP Fusion and FLT3-TKD Mutation: Analysis of Mitelman Database
  Anil Ananthaneni, Taras Benzar, Fatima Iqbal, Hugo Akabane, Society of Hematologic Oncology - 10th Annual Meeting, Houston, TX, 10/1/2022
• Join now to see all